DJ Eli Lilly & Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ shed 3.56% to $789.09 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 4.84% to 5,396.52 and Dow Jones Industrial Average falling 3.98% to 40,545.93.
Eli Lilly & Co. closed 18.86% short of its 52-week high of $972.53, which the company reached on August 22nd.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 2.87% to $159.82, Pfizer Inc. $(PFE)$ fell 1.66% to $24.29, and AbbVie Inc. $(ABBV)$ fell 1.73% to $201.64.
Trading volume (2.7 M) remained 792,926 below its 50-day average volume of 3.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 03, 2025 16:31 ET (20:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。